Stop Losing Revenue to Denials and Audit Fines

Dermatology billing has more moving parts than most specialties because of the frequent blurring of the cosmetic versus medical line, high procedure volume that increases error exposure, and the fact that dermatology practices are often audit magnets. A typical visit can generate three or four procedure codes plus an E/M code and a pathology code, while dermatologists commonly see 30 to 40 patients per day, raising the risk of missing modifiers, incorrect measurements, or wrong code selection.

Medhasty handles every dermatology code correctly, including E/M visits, skin biopsy codes, lesion destruction, excision coding, shave removal, Mohs surgery, cryosurgery, lasers, chemical peels, intralesional injections, cyst removals, and acne surgery. They also manage pathology codes such as 88305 for standard skin biopsies, 88307 for complex cases like melanoma or special stains, and 88309 for large resections.

Medhasty uses a precise modifier strategy that includes applying modifier 25 when billing same-day E/M with a procedure (otherwise the E/M typically denies), using distinct procedural service modifiers when appropriate, applying XS for separate structure or different anatomical site, using LT and RT for paired structures, and applying modifier 50 for bilateral procedures. They note that CMS prefers X-modifiers over modifier 59 when they apply.

Medhasty provides strong compliance and audit protection because dermatology is an OIG audit target. Their services include pre-bill documentation review, modifier validation, medical necessity checks, NCCI compliance, monthly internal audits, provider education, and full support during audits by supplying documentation, responding within deadlines, and appealing adverse findings. Common audit issues they help prevent include incorrect lesion measurement, missing modifier 25, unbundling, and lack of medical necessity documentation.

Medhasty follows a complete revenue cycle management process that starts with eligibility and benefits verification before every appointment, followed by charge capture at the point of service, thorough claim scrubbing for CPT codes, ICD-10 linkages, modifiers, and medical necessity, working every denial within 48 hours by correcting, resubmitting, tracking patterns, and preventing repeats, AR follow-up with daily payment posting and reconciliation while flagging underpayments, and issuing clear patient statements that show what insurance paid and what the patient owes to speed up collections.

Medhasty carefully manages pathology and lab billing because it is a revenue stream many practices mismanage. They address the differences between in-house pathology (where the practice keeps 100% of reimbursement) versus outside lab arrangements (where the lab takes the technical component), correct use of TC and 26 modifiers for splitting components or global billing, and proper selection of skin pathology codes like 88305, 88307, and 88309 to avoid denials or audits. They customize billing based on whether the practice owns the lab or works with outside pathologists.

Medhasty emphasizes that the line between cosmetic and medical dermatology must be drawn carefully because it directly affects reimbursement. Lesion removal is considered medical when there is suspicion of malignancy, pain, itching, bleeding, or documented change, while it is cosmetic when performed purely for appearance. Medicare covers medically necessary procedures with proper documentation, but commercial payers often require prior authorization or have bundling limits, and Medicaid rules vary significantly by state.

Medhasty customizes services to fit each practice’s workflow, payers, and patients rather than using a one-size-fits-all approach. They serve solo practitioners, small group practices, large multispecialty dermatology groups, Mohs surgery centers, dermatopathology laboratories, and teledermatology platforms.

Medhasty highlights that Medicare covers medically necessary dermatology procedures when medical necessity is documented and requires following NCCI bundling edits and correct modifiers, with Mohs surgery coverage limited to specific tumor types and high-risk locations like the face and ears, often needing prior authorization. Commercial payers vary widely with some requiring prior authorization for biopsies, limiting the number of biopsies per visit, or having different bundling rules than Medicare. Medicaid coverage varies by state, with some covering only emergencies or requiring prior authorization for nearly everything.

Practices benefit from cleaner claims that pay faster, fewer denials and repeat issues, stronger audit protection, increased cash flow, transparent and predictable revenue cycle management, no surprises from missed eligibility or charges, and the ability to focus on patient care instead of billing problems. Their process catches errors before submission and works denials quickly while providing customized support.

Yes, Medhasty offers a free billing check and free billing assessment so practices can see exactly where they are losing money due to coding gaps, missing charges, or documentation issues before committing to their services.

The 11400 series is for benign lesions while the 11600 series is for malignant lesions. The correct approach is to use the benign code initially and then update to the malignant code after pathology confirms malignancy.

No. Modifier 25 is required on the E/M code. Without it, the payer typically bundles the E/M into the procedure and denies the E/M charge.

Yes, Medicare covers cryotherapy for actinic keratoses using CPT codes 17110 or 17111, provided the documentation clearly shows the lesions are actinic keratoses and not other benign lesions.

Both indicate distinct procedural service, but modifier XS specifically means separate structure or different anatomical site. CMS prefers the use of X-modifiers over modifier 59 when they apply.

No. Medicare covers Mohs surgery for specific tumor types such as basal cell and squamous cell carcinomas located in high-risk areas like the face and ears, and prior authorization is often required.

Supporting documentation should include lesion characteristics such as size, shape, and color, symptoms like pain, itching, or bleeding, history of change, and clinical suspicion for malignancy. Simply noting that the patient requested removal is not sufficient

Medhasty prevents common errors such as missing modifier 25 on same-day E/M and procedures, incorrect lesion measurements, unbundling of services, lack of medical necessity documentation, wrong pathology code levels, and improper use of modifiers for distinct procedures or bilateral services through pre-bill reviews, claim scrubbing, and ongoing provider education.

Every denial is worked within 48 hours. The team corrects the claim, resubmits it, tracks denial patterns to prevent repeats, and follows up on any underpayments during AR reconciliation to protect revenue.

They provide complete audit support that includes preparing and supplying required documentation, responding to auditor requests within deadlines, and handling appeals of any adverse findings while also conducting monthly internal audits and provider education to reduce future audit risk

Medhasty specializes in dermatology and understands its unique challenges including high procedure volume, complex coding, cosmetic versus medical distinctions, pathology billing nuances, and OIG audit risks. They customize every aspect of billing to the specific practice’s workflow, payers, and patient mix rather than applying generic solutions, which helps practices increase cash flow, reduce denials permanently, and focus on patient care.